| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,847 |
13,206 |
$795K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,282 |
6,839 |
$613K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,831 |
3,829 |
$362K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,228 |
3,217 |
$307K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,889 |
2,869 |
$256K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,194 |
2,190 |
$211K |
| 99051 |
|
872 |
855 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,141 |
1,116 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
434 |
427 |
$17K |
| 87428 |
|
435 |
434 |
$15K |
| 99188 |
|
743 |
742 |
$15K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
160 |
160 |
$14K |
| 90686 |
|
1,505 |
1,497 |
$7K |
| 99215 |
Prolong outpt/office vis |
56 |
51 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
476 |
242 |
$6K |
| 90648 |
|
2,252 |
2,248 |
$6K |
| 90670 |
|
1,601 |
1,598 |
$6K |
| 99381 |
|
54 |
53 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
126 |
124 |
$5K |
| 90723 |
|
1,705 |
1,701 |
$4K |
| 90680 |
|
1,410 |
1,407 |
$4K |
| 90633 |
|
1,314 |
1,313 |
$3K |
| 90734 |
|
317 |
316 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20 |
20 |
$2K |
| 92551 |
|
4,884 |
4,882 |
$2K |
| 90651 |
|
1,057 |
1,053 |
$2K |
| 99383 |
|
16 |
16 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
32 |
30 |
$1K |
| 90716 |
|
407 |
407 |
$1K |
| 90707 |
|
418 |
418 |
$927.00 |
| 96127 |
|
3,059 |
3,056 |
$924.50 |
| 99177 |
|
4,020 |
4,020 |
$865.68 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,789 |
3,788 |
$853.69 |
| 80061 |
Lipid panel |
522 |
521 |
$818.38 |
| 96160 |
|
3,060 |
3,057 |
$808.83 |
| 90700 |
|
424 |
424 |
$620.00 |
| 90710 |
|
481 |
480 |
$616.31 |
| 90715 |
|
376 |
375 |
$585.82 |
| 0071A |
|
14 |
14 |
$528.00 |
| 81002 |
|
114 |
111 |
$394.65 |
| 90696 |
|
430 |
429 |
$374.00 |
| 99173 |
|
218 |
217 |
$100.00 |
| 85018 |
|
745 |
743 |
$55.14 |
| 83655 |
|
897 |
897 |
$38.00 |
| 90619 |
|
625 |
623 |
$0.00 |
| 96161 |
|
2,322 |
2,312 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,121 |
1,086 |
$0.00 |
| 0072A |
|
13 |
13 |
$0.00 |
| 90656 |
|
75 |
75 |
$0.00 |
| 90677 |
|
636 |
635 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$0.00 |
| G9920 |
Screening performed and negative |
2,450 |
2,441 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
50 |
50 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
12 |
12 |
$0.00 |
| 90661 |
|
212 |
212 |
$0.00 |